Under A Partnership Agreement Sarah

Acted for this entity and its subsidiaries in a temporary arbitration proceeding of the LCIA, conducted in London, resulting from a contract to purchase shares under English law. Prior to joining Michael Best Strategies, Sarah was a regulatory advisor at ASTM International. In this capacity, Helton supported the Office global Policy and Industry Affairs in legal, legislative and regulatory matters. She advised on current and emerging federal policies and regulations, which covered various sectors such as energy, the environment, transportation, technology and trade. Sarah has also supported General Counsel in the areas of intellectual property, litigation, employment and contractual matters. She has written numerous comments in response to federal rules and a letter from Amicus to the World Trade Organization. Based on Sarah`s legal and political experience, she has developed important relationships and partnerships with various public and private stakeholders. Acted for this unit in a Chinese-language arbitration proceeding of the Beijing-based CIETAC, with the establishment of a Chinese state oil and gas group as a result of an agreement under the PRC law. Sarah was named Law360 Life Sciences Rising Star in 2020, awarded to lawyers under the age of 40 whose legal benefits believe in their age. Acted for this unit in a Singapore-based SIAC arbitration procedure, resulting from an agreement on the implementation of i.T. systems in accordance with Singapore law. Acted for this unit in a temporary Hong Kong arbitration proceeding, in accordance with UNCITAL rules, resulting from a patent licensing agreement with the subsidiary of a large Chinese publicly traded company with significant legal problems for the PRC.

Ms. Thomas has extensive knowledge of arbitration legislation from all major headquarters and headquarters in the Asia-Pacific region and has represented clients in arbitration proceedings based at various locations, with a particular frequency in Hong Kong, London, Singapore and mainland China. She is experienced in representing clients in ad hoc and administrative proceedings and under a wide range of procedural rules, including those of the International Chamber of Commerce (ICC), the London Court of International Arbitration (LCIA), the Hong Kong International Arbitration Centre (HKIAC), the Singapore International Arbitration Centre (SIAC), the China International Economic Trade and Trade Commission (CIETAC) and the American Arbitration Association (AAA). , in addition to THE CNUDCI arbitration rules. Sarah was involved in the successful resolution of the Hatch Waxman trial, involving the Butrans® transdermal patch, as well as a large number of infringement cases involving the painkiller OxyContin®. More recently, she was part of a team that helped Juno Therapeutics and Sloan Kettering win a final prize of more than $1.1 billion in a case in which the jury found that the accused Kite Pharma had deliberately violated the patent invoked for cancer therapy. She currently represents Merck in patent infringement proceedings against 16 groups of generic defendants related to Bridion®, a first-rate means of reversing certain types of neuromuscular blockage in adults undergoing surgery.